Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma

Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma

Chibby is an antagonist of β-catenin and is considered a potential tumor suppressor protein, but the role of Chibby in hepatocellular carcinoma (HCC) has not been characterized. The expression patterns of Chibby and β-catenin in HCC specimens and paired adjacent noncancerous tissue...

Full description

Bibliographic Details
Main Authors: Ming-Chao Tsai, Chao-Cheng Huang, Yu-Ching Wei, Ting-Ting Liu, Ming-Tsung Lin, Li-Na Yi, Pey-Ru Lin, Chih-Chi Wang, Tian-Huei Chu, Chang-Chun Hsiao, Tsung-Hui Hu, Ming-Hong Tai
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:International Journal of Molecular Sciences
Subjects:
chibby
hepatocellular carcinoma
β-catenin
Online Access:https://www.mdpi.com/1422-0067/21/6/2060

Internet

https://www.mdpi.com/1422-0067/21/6/2060

Similar Items